These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21869709)

  • 1. Refractory adult-onset still disease successfully treated with abatacept.
    Ostrowski RA; Tehrani R; Kadanoff R
    J Clin Rheumatol; 2011 Sep; 17(6):315-7. PubMed ID: 21869709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of abatacept in a refractory case of adult-onset Still's disease.
    Quartuccio L; Maset M; De Vita S
    Clin Exp Rheumatol; 2010; 28(2):265-7. PubMed ID: 20483052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
    Fitzgerald AA; Leclercq SA; Yan A; Homik JE; Dinarello CA
    Arthritis Rheum; 2005 Jun; 52(6):1794-803. PubMed ID: 15934079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anakinra in refractory adult onset Still's disease].
    Vercoutere W; Starmans-Kool M; Peeters RM
    Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult-onset Still's disease in a patient over 80 years old successfully treated with low-dose methotrexate therapy.
    Kurasawa M; Kotani K; Kurasawa G; Shida K; Yamada S; Tago T
    Age Ageing; 2007 Jan; 36(1):104-6. PubMed ID: 17158115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study.
    Nordström D; Knight A; Luukkainen R; van Vollenhoven R; Rantalaiho V; Kajalainen A; Brun JG; Proven A; Ljung L; Kautiainen H; Pettersson T
    J Rheumatol; 2012 Oct; 39(10):2008-11. PubMed ID: 22859346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of refractory adult-onset Still's disease treated with anakinra.
    Lahiri M; Teng GG
    Int J Rheum Dis; 2010 Aug; 13(3):e36-41. PubMed ID: 20704609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anakinra in adult-onset Still's disease: long-term treatment in patients resistant to conventional therapy.
    Giampietro C; Ridene M; Lequerre T; Costedoat Chalumeau N; Amoura Z; Sellam J; Sibilia J; Bourgeois P; Fautrel B;
    Arthritis Care Res (Hoboken); 2013 May; 65(5):822-6. PubMed ID: 23225779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still's disease.
    Tamaki H; Shimizu H; Hiraoka E; Uechi E; Kishimoto M; Yamaguchi K; Okada M
    Mod Rheumatol; 2010 Apr; 20(2):200-4. PubMed ID: 20037747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and management of adult-onset Still's disease.
    Efthimiou P; Georgy S
    Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult-onset Still's disease: Advances in the treatment.
    Castañeda S; Blanco R; González-Gay MA
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.
    Sfriso P; Bindoli S; Galozzi P
    Drugs; 2018 Aug; 78(12):1187-1195. PubMed ID: 30069732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra).
    Fischer-Betz R; Specker C; Schneider M
    Clin Exp Rheumatol; 2011; 29(6):1021-3. PubMed ID: 22153586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of refractory adult onset Still's disease with rituximab.
    Belfeki N; Smiti Khanfir M; Said F; Hamzaoui A; Ben Salem T; Ben Ghorbel I; Lamloum M; Houman MH
    Reumatismo; 2016 Dec; 68(3):159-162. PubMed ID: 27981819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?
    Efthimiou P; Kontzias A; Ward CM; Ogden NS
    Nat Clin Pract Rheumatol; 2007 Jun; 3(6):328-35. PubMed ID: 17538564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic treatments for adult-onset Still's disease.
    Al-Homood IA
    Rheumatology (Oxford); 2014 Jan; 53(1):32-8. PubMed ID: 23864171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences.
    Kraetsch HG; Antoni C; Kalden JR; Manger B
    Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii55-7. PubMed ID: 11890655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature.
    Thonhofer R; Hiller M; Just H; Trummer M; Siegel C; Dejaco C
    Rheumatol Int; 2011 Dec; 31(12):1653-6. PubMed ID: 21240503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Longterm outcome of TNF blockade in adult-onset Still's disease].
    Dechant C; Schauenberg P; Antoni CE; Kraetsch HG; Kalden JR; Manger B
    Dtsch Med Wochenschr; 2004 Jun; 129(23):1308-12. PubMed ID: 15179590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.